Tuesday, March 02, 2021 2:47:51 PM
This is a confusing statement to me as well. She definitely seems jaded by the clinical trial process, and it's also a reasonable inference to conclude that she's become jaded with NWBO specifically. Her statement regarding NWBO's patent strategy certainly suggests that she's not a fan of the company. But is that really all that surprising? She's trying to cure cancer, not make money. I think it's safe to say that Dr. Liau is the most frustrated person in the world over the delay in getting DCVAX-L approved...she's bound to place at least some of the blame for the delay on NWBO, rightly or wrongly. And as others have pointed out, she's not a patent attorney. So even though she may have some kind of moral objection to NWBO's patent strategy, that doesn't invalidate their existing patents.
At the end of the day, I think what she's getting at is that DCVAX-L is not a cure for most people and thus, her mission is not complete and she's still searching for an answer. However, if DCVAX-L is a cure for some people, and if it extends life in enough other people, then DCVAX-L will get approved and if the patient population is large enough, it will be a home run financially, especially if it works for other indications, which it should.
Fun fact of the day: Malloy's wife is still alive 2 years after her diagnosis, which is 16 months longer than she was originally told she had to live. How wonderful for the Malloy family! I pray that she continues to stay healthy.
At the end of the day, I think what she's getting at is that DCVAX-L is not a cure for most people and thus, her mission is not complete and she's still searching for an answer. However, if DCVAX-L is a cure for some people, and if it extends life in enough other people, then DCVAX-L will get approved and if the patient population is large enough, it will be a home run financially, especially if it works for other indications, which it should.
Fun fact of the day: Malloy's wife is still alive 2 years after her diagnosis, which is 16 months longer than she was originally told she had to live. How wonderful for the Malloy family! I pray that she continues to stay healthy.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
